According to a recently released Future Market Insights report, the overall market value is estimated to be around US$ 507.3 million in 2023. The global demand for 3D printed maxillofacial implants is expected to display a CAGR of 8.2% while amassing a market value worth of US$ 1,119.1 million by 2033.
The global market exhibited a CAGR of 3.6% between 2018 and 2022 concluding at a net worth of US$ 483.8 million in 2022. Increasing demand for 3D printed maxillofacial implants is due to reduced surgical times and elimination of constraints of shape, internal structure, and size.
Surging cases of road accidents owing to industrialization and urbanization and growing demand for effective reconstructive surgeries are projected to offer various opportunities for expansion to the 3D printed maxillofacial market. Growing demand for minimally invasive surgeries is anticipated to augment the 3D printed maxillofacial market during the assessment period.
The increasing prevalence of facial fractures is likely to lead mainly from combat sports. Furthermore, the expanding geriatric population and rising healthcare expenditures are other factors contributing to the growth of the 3D printed maxillofacial implants market during the forecast period.
| Report Attributes | Details |
|---|---|
| Global 3D Printed Maxillofacial Implants Market Valuation in 2022 | US$ 483.8 million |
| Estimated Global Market Share in 2023 | US$ 507.3 million |
| Forecasted Global Market Size by 2033 | US$ 1,119.1 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 8.2% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 3.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing Prevalence of Facial Injuries to Boost the Demand for 3D Printed Maxillofacial Implants
As per the Centers for Disease Control and Prevention (CDC), 1.7 to 3.8 million traumatic brain injuries are reported annually in the United States. Out of these, 10% arise due to sports and recreational activities. In 2018, the United States Consumer Product Safety Commission (CPSC) data revealed that 454,407 sports-related head injuries were treated in the United States. Such facts and figures are expected to widen the scope of 3D-printed maxillofacial implant growth during the forecast period.
The growing prevalence of facial injuries and fractures is anticipated to drive the demand for maxillofacial implant equipment in the forthcoming years. Some of the most vital factors driving the incidence of facial fractures include incidents such as domestic accidents, motor vehicle accidents, violence, work-related injuries, and sports, among others. Among all, road traffic accidents are likely to secure a dominant share of maxillofacial trauma events.
Growing Approvals by Regulatory Authorities to Pose Significant Opportunities to the 3D-Printed Maxillofacial Implants Market
Increasing approvals of the equipment by authorities such as the FDA is expected to offer significant opportunities for expansion during the forecast period. For instance, In July 2022, a 3D printed bone graft from medical equipment manufacturer Cerhum obtained approval for use in Europe.
MyBone is the first commercially available 3D printed bone graft authorized under the Medical Device Regulation 2017/745 and has also been ISO 13485 certified. As a result, the patient-specific bone graft will now be made available to maxillofacial and orthopedic surgeons throughout the continent. Such factors are likely to strengthen the 3D printed maxillofacial implants market during the forecast period.
Principal Consultant
Lack of Awareness to Limit the 3D Printed Maxillofacial Implants Market
Lack of awareness about the market is expected to act as a significant factor limiting the market growth during the forecast period. Further, high expenses associated with a 3D printed maxillofacial implant are another cause hindering the development of the market in the assessment period.
Growing technological development in maxillofacial implants is expected to act as a significant counter to the hampering factors and assist in market growth during the forecast period.
Maximum Benefits Offered by Healthcare Settings to Strengthen the Hospital Segment
The study reveals that the hospital segment is likely to dominate the global 3D printed maxillofacial implants market during the forecast period. In 2021, the segment garnered at US$ 822.5 million.
Domination of the segment can be attributed to the fact that maximum maxillofacial surgeries are conducted in hospitals due to the presence of technologically developed equipment, facilities, and expertise in these healthcare settings.
Other provisions like intensive care units and post-surgical support might lead to many people going to hospitals. Thus, due to various benefits provided by these healthcare settings, the hospital segment is going to exhibit various prospects of growth in the forecast period.
| Category | By End User Vertical |
|---|---|
| Top Segment | Hospital |
| Market Share in Percentage | 73.3% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Growing Approvals by FDA for Key Equipment to widen Market Growth Prospects
According to FMI’s analysis, North America is anticipated to dominate the global market during the forecast period. In 2022, the region claimed 37.4% of the total market share. The United States is anticipated to make the maximum contribution to developing the regional market.
Expansion of the regional market is majorly attributed to the expanding geriatric population along with the presence of renowned international players in the region. Also, the number of surgeries performed in the United States is high and is multiplying each year which is projected to have a positive impact on the market during the forecast period.
Growing approval by the United States FDA for key 3D printed maxillofacial equipment is anticipated to fuel the market growth in the forecast period. In October 2020, Pioneering 3D printer manufacturer 3D Systems announced that it received 510(k) clearance from the FDA to 3D print maxillofacial surgical guides using its LaserForm Ti and DuraFormProX PA materials. Such factors are expected to make significant contributions to the market growth in the forecast period.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 37.2% |
| Europe | 28.4% |
Introduction of New Products in Europe’s Market to Develop the Regional Market
According to Future Market Insights, Europe’s 3D printed maxillofacial implants market is anticipated to be the second-largest market during the forecast period. In 2022, the region secured 29.2% of the global market share.
Expansion of the regional market can be attributed to the growing launch of new products in the market. For instance, in 2019, Evonik rolled out new radiopaque material, PEEK, which can be used for implant technology. The newly launched material can be used in maxillofacial implants. It also offers enhanced bio-stability and biocompatibility.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| The United States | 34.7% |
| Germany | 7.3% |
| Japan | 4.6% |
Ongoing Research and Development in the Field to Drive Asia Pacific’s 3D Printed Maxillofacial Implants Market
Asia Pacific is projected to be the most significant market during the forecast period, expected to display a CAGR of 7.7% until 2033. This can be attributed to the presence of untapped market opportunities in the region. Developing countries like India, China, Japan, and others, are likely to hold significant market opportunities in the region.
Ongoing research and development in developing countries of the region is expected to develop the market in the coming time. For instance,
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| The United Kingdom | 7% |
| China | 9.1% |
| India | 7.9% |
| Australia | 6.3% |
Ongoing research and development in the 3D printed maxillofacial implants is expected to encourage new players to enter the market, thus, augmenting the market size notably. Some of the names gaining popularity include Maxillofacial Implants (India), Avay (India), Seinser Implants (India), Nasseo (US), Keystone Dental (2006), iDentical (US), 3di GmbH (Germany), BioMaterals Korea, Inc. (Korea), Zoriox Innovation Labs (India), and others. Emerging players in the market are making notable contributions to developing the market. For instance,
Key players in the global 3D printed maxillofacial implants market include Materialise, Zimmer Biomet, Medartis, DePuySynthes, and others.
Recent Industry Updates include:
| Report Attributes | Details |
|---|---|
| Growth Rate (2023 to 2033) | 8.2% CAGR |
| Market Value in 2023 | US$ 507.3 million |
| Market Value in 2033 | US$ 1,119.1 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | US$ million or US$ billion for Value |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization Scope | Available upon Request |
The market is valued at US$ 507.3 million in 2023.
The market rose at a 3.6% CAGR from 2018 to 2022.
The market will reach US$ 1,119.1 million by 2033.
The market’s CAGR from 2023 to 2033 will be 8.2%.
In 2022, the North America claimed 37.4% of the total market share.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By End-User, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-User, 2023 to 2033
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Ambulatory Surgical Centers
5.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By End-User
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By End-User
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By End-User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By End-User
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By End-User
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By End-User
10.4. Key Takeaways
11. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By End-User
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By End-User
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By End-User
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By End-User
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By End-User
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By End-User
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By End-User
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By End-User
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By End-User
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By End-User
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By End-User
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By End-User
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By End-User
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By End-User
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By End-User
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By End-User
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By End-User
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By End-User
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By End-User
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By End-User
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By End-User
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Johnson & Johnson Services
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Materialise
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Stryker Corporation
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Zimmer Biomet Holdings
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. B. Braun Melsungen
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Medtronic Plc.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Boston Medical Products
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Integra Lifesciences
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. KLS Martin
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Medartis
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Healthcare Insights
View Reports
3D Printed Maxillofacial Implants Market
